WBR0536: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Sergekorjian (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{ | |QuestionAuthor={{YD}} {{Alison}} (Reviewed by Serge Korjian) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
Line 8: | Line 8: | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
|SubCategory=Neurology | |SubCategory=Neurology | ||
|MainCategory=Pharmacology | |||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
Line 20: | Line 21: | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
|SubCategory=Neurology | |SubCategory=Neurology | ||
|Prompt=A 10-year-old | |Prompt=A 10-year-old boy is brought to the pediatrician's office for declining school performance and poor concentration. The mother explains that her child is a day dreamer and is concerned about his recurrent blank stares. She is fearful that her son has attention deficit disorder (ADD). Following an extensive work-up, the patient is diagnosed with seizure disorder and treatment is initiated. Which of the following mechanisms of action corresponds to the medication prescribed to this patient? | ||
|Explanation=[[Ethosuximide]], a succinimide antiepileptic drug, is the first line treatment for absence seizure (petit mal). It is a low voltage-activated thalamic T-type calcium channel blocker. | |Explanation=[[Ethosuximide]], a succinimide antiepileptic drug, is the first line treatment for absence seizure (petit mal). It is a low voltage-activated thalamic T-type calcium channel blocker. | ||
Line 26: | Line 27: | ||
In addition, valproic acid can often be used to treat absence seizures as well. | In addition, valproic acid can often be used to treat absence seizures as well. | ||
|AnswerA=Inactivation of dopamine receptors | |AnswerA=Inactivation of dopamine receptors | ||
|AnswerAExp=Antipsychotics are used to treat psychiatric diseases, such as schizophrenia, act by inactivation of dopamine receptors. | |AnswerAExp=Antipsychotics are used to treat psychiatric diseases, such as schizophrenia, act by inactivation of dopamine receptors. | ||
|AnswerB=Inactivation of sodium channels but not effect on GABA | |AnswerB=Inactivation of sodium channels but not effect on GABA | ||
|AnswerBExp=Phenytoin's mechanism of action is the inactivation of sodium channels. Although Phenytoin is not commonly administered to treat absence seizures, it is used in tonic-clonic generalized seizure and partial seizures. | |AnswerBExp=Phenytoin's mechanism of action is the inactivation of sodium channels. Although Phenytoin is not commonly administered to treat absence seizures, it is used in tonic-clonic generalized seizure and partial seizures. | ||
|AnswerC=Concomitant inactivation of sodium channels and activation of GABA | |AnswerC=Concomitant inactivation of sodium channels and activation of GABA | ||
Line 40: | Line 37: | ||
|AnswerE=Inhibition of GABA reuptake | |AnswerE=Inhibition of GABA reuptake | ||
|AnswerEExp=Tiagabine, which acts by inhibition of GABA reuptake, is effective in partial seizures, but is not usually used to treat absence seizures. | |AnswerEExp=Tiagabine, which acts by inhibition of GABA reuptake, is effective in partial seizures, but is not usually used to treat absence seizures. | ||
|EducationalObjectives=[[Ethosuxamide]], the first line treatment for absence seizures, is a thalamic T-type calcium channel blocker. | |||
|References=First Aid 2014 page 485 | |||
|RightAnswer=D | |RightAnswer=D | ||
|WBRKeyword=absence seizure, seizures, petit mal, ethosuximide, calcium channel blocker, t-type, mechanism of action, neurological, | |WBRKeyword=absence seizure, seizures, petit mal, ethosuximide, calcium channel blocker, t-type, mechanism of action, neurological, | ||
|Approved=Yes | |Approved=Yes | ||
}} | }} |
Revision as of 17:26, 17 February 2015
Author | [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Alison Leibowitz) (Reviewed by Serge Korjian)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pharmacology |
Sub Category | SubCategory::Neurology |
Prompt | [[Prompt::A 10-year-old boy is brought to the pediatrician's office for declining school performance and poor concentration. The mother explains that her child is a day dreamer and is concerned about his recurrent blank stares. She is fearful that her son has attention deficit disorder (ADD). Following an extensive work-up, the patient is diagnosed with seizure disorder and treatment is initiated. Which of the following mechanisms of action corresponds to the medication prescribed to this patient?]] |
Answer A | AnswerA::Inactivation of dopamine receptors |
Answer A Explanation | AnswerAExp::Antipsychotics are used to treat psychiatric diseases, such as schizophrenia, act by inactivation of dopamine receptors. |
Answer B | AnswerB::Inactivation of sodium channels but not effect on GABA |
Answer B Explanation | AnswerBExp::Phenytoin's mechanism of action is the inactivation of sodium channels. Although Phenytoin is not commonly administered to treat absence seizures, it is used in tonic-clonic generalized seizure and partial seizures. |
Answer C | AnswerC::Concomitant inactivation of sodium channels and activation of GABA |
Answer C Explanation | AnswerCExp::Topiramate blocks sodium channels and increases the action of GABA. It is not commonly administered to treat absence seizures, but is effective in treating partial and tonic-clonic generalized seizures. |
Answer D | AnswerD::Inactivation of thalamic T-type calcium channels |
Answer D Explanation | AnswerDExp::See overall explanation. |
Answer E | AnswerE::Inhibition of GABA reuptake |
Answer E Explanation | AnswerEExp::Tiagabine, which acts by inhibition of GABA reuptake, is effective in partial seizures, but is not usually used to treat absence seizures. |
Right Answer | RightAnswer::D |
Explanation | [[Explanation::Ethosuximide, a succinimide antiepileptic drug, is the first line treatment for absence seizure (petit mal). It is a low voltage-activated thalamic T-type calcium channel blocker.
Ethosuximide has a rare frequency of adverse drug reactions. Most common side effects include GI distress, fatigue, and headache. A less common, but more severe side effect is Stevens-Johnson syndrome, a dermatologic disorder characterized by fever, bullous formation, and necrosis with skin sloughing. In addition, valproic acid can often be used to treat absence seizures as well. |
Approved | Approved::Yes |
Keyword | WBRKeyword::absence seizure, WBRKeyword::seizures, WBRKeyword::petit mal, WBRKeyword::ethosuximide, WBRKeyword::calcium channel blocker, WBRKeyword::t-type, WBRKeyword::mechanism of action, WBRKeyword::neurological |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |